02/26/2024 6:32 PM | Lee Sung (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/26/2024 6:32 PM | De Backer Marianne (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/26/2024 6:34 PM | HANLY ANN M. (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/26/2024 6:30 PM | SCANGOS GEORGE A (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/26/2024 6:31 PM | Pang Phillip (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/26/2024 3:32 PM | SCANGOS GEORGE A (Reporting) Vir Biotechnology (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024 8:02 PM | SCANGOS GEORGE A (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
02/20/2024 3:35 PM | SCANGOS GEORGE A (Reporting) Vir Biotechnology (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024 5:56 PM | Pang Phillip (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/24/2024 6:59 AM | STATE STREET CORP (Filed by) Vir Biotechnology (Subject)
| Form SC 13G | |
01/23/2024 3:14 PM | BlackRock Inc. (Filed by) Vir Biotechnology (Subject)
| Form SC 13G/A | |
01/03/2024 1:47 PM | Pang Phillip (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/03/2023 3:33 PM | Vir Biotechnology (Filer)
| Form S-3ASR | |
11/03/2023 3:37 PM | Vir Biotechnology (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/20/2023 1:15 PM | MORE ROBERT J (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/18/2023 1:14 PM | SCANGOS GEORGE A (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2023 7:01 AM | Vir Biotechnology (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/20/2023 5:02 AM | Vir Biotechnology (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/18/2023 2:54 PM | SCANGOS GEORGE A (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/03/2023 3:14 PM | Vir Biotechnology (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/20/2023 7:04 AM | Vir Biotechnology (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/05/2023 8:00 PM | SVF Endurance Ltd (0001782338) (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2023 3:15 PM | SATO VICKI L (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/30/2023 8:00 PM | SVF Endurance Ltd (0001782338) (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/30/2023 4:17 PM | SATO VICKI L (Reporting) Vir Biotechnology (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/29/2023 4:01 PM | SVF Endurance Ltd (0001782338) (Reporting) Vir Biotechnology (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/22/2023 8:00 PM | SVF Endurance Ltd (0001782338) (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2023 8:00 PM | SVF Endurance Ltd (0001782338) (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 8:00 PM | SVF Endurance Ltd (0001782338) (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 3:30 PM | Pang Phillip (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2023 8:00 PM | SVF Endurance Ltd (0001782338) (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2023 4:58 PM | Horn Howard (Reporting) Vir Biotechnology (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/02/2023 11:19 AM | Ramasastry Saira (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2023 11:20 AM | Rice Steven J. (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/01/2023 3:25 PM | Ramasastry Saira (Reporting) Vir Biotechnology (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/01/2023 3:27 PM | Rice Steven J. (Reporting) Vir Biotechnology (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/25/2023 8:00 PM | SVF Endurance Ltd (0001782338) (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 3:16 PM | NELSEN ROBERT (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 1:34 PM | Hatfield Jeffrey S. (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 1:35 PM | SHARP PHILLIP A (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 1:37 PM | SATO VICKI L (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Warning: this could blow your mind (Ad) Buckle up…
‘Cause this might shatter everything you’ve heard about “income trading”.
In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it:
The Perfect Income Trade
You see, most of the income techniques out there target a couple of percent.
Maybe 5 - 10 percent if you’re lucky.
But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return.
And here’s the best news of all:
This trade can target an opportunity like that every week. Every single week.
Meaning an investor has the chance to “stack up” these more aggressive income trades over and over.
If that sounds interesting… Watch the presentation here |
05/24/2023 1:41 PM | MORE ROBERT J (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 1:42 PM | Napolitano Janet (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 1:44 PM | Ramasastry Saira (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 1:44 PM | PEREZ ROBERT J (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 1:33 PM | Sigal Charles Elliott (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2023 8:00 PM | SVF Endurance Ltd (0001782338) (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2023 3:06 PM | Vir Biotechnology (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2023 8:00 PM | SVF Endurance Ltd (0001782338) (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/05/2023 8:00 PM | SVF Endurance Ltd (0001782338) (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/03/2023 8:00 PM | SVF Endurance Ltd (0001782338) (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/26/2023 8:00 PM | SVF Endurance Ltd (0001782338) (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/24/2023 8:00 PM | SVF Endurance Ltd (0001782338) (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/20/2023 8:00 PM | SVF Endurance Ltd (0001782338) (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/18/2023 8:00 PM | SVF Endurance Ltd (0001782338) (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/07/2023 3:07 PM | Vir Biotechnology (Filer)
| Form DEF 14A | |
04/07/2023 3:09 PM | Vir Biotechnology (Filer)
| Form DEFA14A | |
04/07/2023 3:12 PM | Vir Biotechnology (Filer)
| Form ARS | |
04/04/2023 3:51 PM | De Backer Marianne (Reporting) Vir Biotechnology (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
04/04/2023 3:53 PM | De Backer Marianne (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/29/2023 4:49 PM | Lee Sung (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/29/2023 4:47 PM | Lee Sung (Reporting) Vir Biotechnology (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |